文献速递创伤骨科骨质疏松与代谢性骨病

特立帕肽促进非典型股骨骨折愈合的每日与每周给药比较

The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration.
PubMed 文献 · Osteoporos Int · 2018-08-13

本研究纳入43例日本患者的45处非典型股骨骨折,比较每日20微克与每周56.5微克特立帕肽注射对骨愈合的促进作用。全部患者中两组骨折愈合时间无显著差异;完全性非典型股骨骨折患者中每日组愈合时间(6.1±4.1个月)显著短于每周组(10.1±4.2个月)(P<0.05)。

要点

  • 全部非典型股骨骨折患者中,每日与每周特立帕肽组的骨折愈合时间无显著差异。
  • 完全性非典型股骨骨折患者中,每日组骨折愈合时间显著短于每周组(P<0.05)。
  • 不完全性非典型股骨骨折患者中,两组骨折愈合时间无显著差异。

核心结论

  • 在完全性非典型股骨骨折患者中,每日注射特立帕肽比每周注射更能促进骨愈合。

研究设计与样本

  • 研究纳入43例日本患者的45处连续性非典型股骨骨折,每日组32处接受每日20微克特立帕肽注射,每周组13处接受每周一次56.5微克特立帕肽注射。

主要发现

  • 全部患者中,两组骨折愈合时间无显著差异。
  • 完全性非典型股骨骨折患者中,每日组双膦酸盐或地舒单抗注射次数显著少于每周组(P<0.05)。
  • 完全性非典型股骨骨折患者中,每日组骨折愈合时间(6.1±4.1个月)显著短于每周组(10.1±4.2个月)(P<0.05)。
  • 排除双膦酸盐或地舒单抗使用的影响后,完全性非典型股骨骨折患者中两组骨折愈合时间仍存在相似的显著差异(P<0.05)。
  • 不完全性非典型股骨骨折患者中,两组骨折愈合时间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: We compared the effectiveness of promoting bone healing between two teriparatide preparations for atypical femoral fracture (AFF). A total of 45 AFFs were included in this study, and we compared the duration of bone union. Teriparatide administered by daily injection enhanced bone union more than weekly administration in complete AFFs. INTRODUCTION: The efficacy of teriparatide for atypical femoral fracture (AFF) has been recently reported. Although two different teriparatide preparations can be used to treat osteoporosis in Japan, daily or weekly injection, all previous reports on the effectiveness of teriparatide for AFF only examined daily injection formulations. Therefore, we compared the promotion of bone healing between the two teriparatide preparations for AFF. METHODS: A total of 45 consecutive AFFs in 43 Japanese patients were included in this study. They received either a daily 20-μg teriparatide injection (daily group; n = 32) or a once-a-week 56.5-μg teriparatide injection (weekly group; n = 13). We compared the clinical background and duration of bone union between these two groups. RESULTS: When all patents were included, the fracture healing time was not significantly different between the two groups. Only patients with complete AFFs had significantly fewer daily bisphosphonate or denosumab injections than the weekly group (P < 0.05). The fracture healing time in the daily group (6.1 ± 4.1 months) was significantly shorter than that in the weekly group (10.1 ± 4.2 months) (P < 0.05). Even if the influence of bisphosphonate or denosumab usage was excluded, a similar significant difference was observed in the fracture healing time (P < 0.05). There was no significant difference between the two groups among patients with incomplete AFFs. CONCLUSIONS: Daily teriparatide injections enhance bone union more than weekly injections in complete AFF patients.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Tsuchie H, Miyakoshi N, Iba K, et al. The effects of teriparatide on acceleration of bone healing following atypical femoral fracture: comparison between daily and weekly administration. Osteoporos Int. 2018. PMID: 30105400. doi:10.1007/s00198-018-4658-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。